CANDIDO, RICCARDO
 Distribuzione geografica
Continente #
NA - Nord America 3.986
EU - Europa 1.757
AS - Asia 597
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 6
OC - Oceania 4
Totale 6.370
Nazione #
US - Stati Uniti d'America 3.968
PL - Polonia 565
SE - Svezia 358
IT - Italia 305
HK - Hong Kong 232
UA - Ucraina 231
CN - Cina 225
FI - Finlandia 88
TR - Turchia 76
BG - Bulgaria 44
IE - Irlanda 43
GB - Regno Unito 40
DE - Germania 29
SG - Singapore 20
BE - Belgio 18
KR - Corea 17
FR - Francia 15
CA - Canada 11
EU - Europa 8
SN - Senegal 8
IN - India 7
MX - Messico 7
VN - Vietnam 6
BR - Brasile 5
AU - Australia 4
CZ - Repubblica Ceca 4
ES - Italia 4
JP - Giappone 4
RU - Federazione Russa 4
CH - Svizzera 3
IR - Iran 3
EG - Egitto 2
SI - Slovenia 2
TH - Thailandia 2
AT - Austria 1
CL - Cile 1
ID - Indonesia 1
MY - Malesia 1
NL - Olanda 1
NO - Norvegia 1
PK - Pakistan 1
RO - Romania 1
SY - Repubblica araba siriana 1
TG - Togo 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 6.370
Città #
Warsaw 565
Ann Arbor 532
Woodbridge 491
Fairfield 454
Houston 428
Chandler 372
Ashburn 281
Hong Kong 232
Seattle 227
Jacksonville 206
Wilmington 200
Cambridge 152
Princeton 78
Beijing 72
Izmir 66
Trieste 59
Boardman 54
Sofia 43
Dublin 40
Dearborn 36
San Diego 23
Shanghai 21
Brussels 18
Helsinki 18
Seoul 16
Segrate 13
Venice 13
Jinan 12
Columbus 11
Falls Church 11
Mestre 11
Phoenix 10
Chicago 9
Milan 9
Dakar 8
Kocaeli 8
Padova 8
Redmond 8
Dongguan 7
Düsseldorf 7
Nanjing 7
St. Catharines 7
Venezia 7
Dong Ket 6
Norwalk 6
Shenyang 6
Washington 6
Berlin 5
Buffalo 5
Fuzhou 5
Hebei 5
Kunming 5
Milpa Alta 5
Bari 4
Nanchang 4
São Paulo 4
Tokyo 4
Torviscosa 4
Calcinaia 3
Des Moines 3
Fremont 3
Guangzhou 3
Manchester 3
Messina 3
Monfalcone 3
Montreal 3
Moscow 3
Pune 3
Redwood City 3
Rome 3
Taizhou 3
Tehran 3
Verona 3
Zhengzhou 3
Auburn Hills 2
Bangkok 2
Baotou 2
Bern 2
Bremen 2
Brno 2
Campi Bisenzio 2
Castelfranco Veneto 2
Catania 2
Chennai 2
Chongqing 2
Gemona 2
Hangzhou 2
Harbin 2
Istanbul 2
Lappeenranta 2
Leawood 2
Libertyville 2
London 2
Los Angeles 2
Madrid 2
New York 2
Palaia 2
Paluzza 2
Paris 2
Perth 2
Totale 5.024
Nome #
Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease 340
A new ultrasonographic instrument for measuring vessel wall shear stress. 336
Circulating osteoprotegerin is associated with chronic kidney disease in hypertensive patients 317
Large-artery hemodynamics after acute alcohol administration in young, healthy volunteers 220
Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets. 189
Innate immunity, through late complement components activation, contributes to the development of early vascular inflammation and morphologic alterations in experimental diabetes. 182
Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes 182
TRAIL shows potential cardioprotective activity. 177
Angiotensin 1-7 significantly reduces diabetes-induced leukocyte recruitment both in vivo and in vitro 176
Haemoconcentration, shear-stress increase and carotid artery diameter regulation after furosemide administration in older hypertensives 168
Stimulation of cardiac apoptosis in ovariectomized hypertensive rats: potential role of the renin-angiotensin system 163
Cardiac and nephroprotective effects of angiotensin converting enzyme inhibitor treatment in the renal ablation model. 163
TNF-related apoptosis-inducing ligand significantly attenuates metabolic abnormalities in high-fat-fed mice reducing adiposity and systemic inflammation 162
Prevention of accelerated atherosclerosis by AT1 receptor blockade in experimental renal failure. 160
Mechanics of the carotid artery wall and baroreflex sensitivity after acute ethanol administration in young healthy volunteers 148
Strategies used by Patients with Type 1 Diabetes to Avoid Hypoglycemia in a 24×1-Hour Marathon: Comparison with the Amounts of Carbohydrates Estimated by a Customizable Algorithm 148
Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice 139
ACE2 deficiency shifts energy metabolism towards glucose utilization 137
Patients affected by metabolic syndrome show decreased levels of circulating platelet derived growth factor (PDGF)-BB 135
Endothelial dysfunction (ED) in familial hypercholesterolemia (FH). Role of the LDL-cholesterol (LDL) variations after LDL-aphaeresis (LDL-A) vs medical therapy 134
Comparative effects of antihypertensive and/or antioxidative treatment in an experimental model of chronic progressive nephrosis 134
Orally administered microencapsulated lysozyme downregulates serum AGE and reduces the severity of early-stage diabetic nephropathy 133
Control of glomerular hyperfiltration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats 131
Contribution of Systemic Blood-pressure To Myocardial Remodeling In Uremic Rats 129
Haemoconcentration, shear-stress elevation and carotid artery diameter regulation after furosemide in older hypertensives 125
Effects of prolonged high-altitude exposure on peripheral adrenergic receptors in young healthy volunteers. 125
Human full-length osteoprotegerin induces the proliferation of rodent vascular smooth muscle cells both in vitro and in vivo. 122
null 120
Does renal function influence the prognostic impact of type 2 diabetes mellitus in patients with chronic heart failure and left ventricular dysfunction? 115
Hypertension and diabetes: emphasis on the renin-angiotensin system in atherosclerosis 114
Linking diabetes and atherosclerosis 113
Regional and systemic haemodynamic response to aortography in hypertensives. 112
Effects of central alpha 2-adrenergic agonists on systemic haemodynamics and on baroreceptor reflex sensitivity in spontaneously hypertensive rats. 112
Angiotensin II promotes apoptosis in ventricular cardiomyoctes in vivo 98
In vivo effects of fluvastatin on leukocyte vascular trafficking under experimental acute inflammatory conditions 88
Modulation of incipient glomerular lesions in experimental diabetic nephropathy by hypotensive and subhypotensive doses of an ACE inhibitor 78
Forearm endothelial dysfuncion (ED) is a marker of the epato-renal vascular impairment but not of the systemic haemodynamic control in cirrhotic patients 76
Personalized Approach for the Management of Exercise-Related Glycemic Imbalances in Type 1 Diabetes: Comparison with Reference Method 51
Type 1 diabetes is associated with significant changes of ACE and ACE2 expression in peripheral blood mononuclear cells 49
Gadolinium tissue deposition in the periodontal ligament of mice with reduced renal function exposed to Gd-based contrast agents 47
Modulation of incipient glomerular lesions in experimental diabetic nephropathy by hypotensive and subhypotensive dosages of an ACE inhibitor 44
Deep-learning-based prognostic modeling for incident heart failure in patients with diabetes using electronic health records: a retrospective cohort study 35
Preliminary Study on the Effect of a Night Shift on Blood Pressure and Clock Gene Expression 27
Effect of insulin secretagogues on major cardiovascular events and all-cause mortality: A meta-analysis of randomized controlled trials. 24
Effects of glucose-lowering agents on cardiovascular and renal outcomes in subjects with type 2 diabetes: An updated meta-analysis of randomized controlled trials with external adjudication of events 22
ACE-inhibitor treatment prevents cardiac remodelling in experimental uremia 22
A new ultrasonographic instrument for measuring vessel wall shear stress: comparison to a mathematical model in essential hypertensives 21
An integrated care pathway for cancer patients with diabetes: A proposal from the Italian experience 20
Safety and Appropriateness in the Management of the Treatment Pathway of Pregnant Women with Gestational Diabetes 20
Effect of metformin on all-cause mortality and major adverse cardiovascular events: An updated meta-analysis of randomized controlled trials. 20
Effectiveness, Safety, and Appropriateness in the Use of the Fixed-Ratio Combination of Insulin Glargine and Lixisenatide in Type 2 Diabetes: The ENSURE Retrospective Real-World Study 20
Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials 20
Generalizability of Cardiovascular Safety Trials on SGLT2 Inhibitors to the Real World: Implications for Clinical Practice 19
Effects of Dipeptidyl Peptidase-4 Inhibitor Linagliptin on Left Ventricular Dysfunction in Patients with Type 2 Diabetes and Concentric Left Ventricular Geometry (the DYDA 2™ Trial). Rationale, Design, and Baseline Characteristics of the Study Population 19
AMD Annals: a model of continuous monitoring and improvement of the quality of diabetes care 19
Sinergia collaborativa nella gestione del paziente diabetico con recente sindrome coronarica acuta 18
Effects of insulin on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials 18
A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus 18
La territorializzazione del farmaco in epoca di PNRR: prospettive, opportunità e spunti di riflessione da un panel di esperti 18
Algorithms for personalized therapy of type 2 diabetes: results of a web-based international survey 18
Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products 17
Uncovering Predictors of Lipid Goal Attainment in Type 2 Diabetes Outpatients Using Logic Learning Machine: Insights from the AMD Annals and AMD Artificial Intelligence Study Group 17
A new ultrasonographic instrument for measuring vessel wall shear stress: Comparison to a mathematical model in essential hypertensives 17
Improvement of glycemic control in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials 17
Italian guidelines for the treatment of type 2 diabetes 17
Delphi-Based Consensus on Treatment Intensification in Type 2 Diabetes Subjects Failing Basal Insulin Supported Oral Treatment: Focus on Basal Insulin + GLP-1 Receptor Agonist Combination Therapies 16
ACE inhibitors (ACEI) prevent an early albumin permeability defect in isolated glomeruli from streptozotocin-treated rats 16
The AMD ANNALS: A continuous initiative for the improvement of type 2 diabetes care 16
Effects of pioglitazone on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials 16
Clinical Inertia Is the Enemy of Therapeutic Success in the Management of Diabetes and Its Complications: A Narrative Literature Review 15
2023 update on Italian guidelines for the treatment of type 2 diabetes 15
Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis 15
A new ultrasonographic instrument for measuring vessel wall shear stress: comparison to a mathematical model in essential hypertensives 15
ACE inhibitor treatment prevents cardiac programmed cell death and intermyocardiocytic fibrosis in hypertensive diabetic rats 14
Italian guidelines for the treatment of type 2 diabetes 14
All-cause mortality and cardiovascular events in patients with type 2 diabetes treated with alpha-glucosidase inhibitors: A meta-analysis of randomized controlled trials 13
Ace Inhibitor treatment prevents renal growth and hyperfiltration in streptozotocin diabetic rats 12
A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes 11
ACE inhibitors (ACEI) prevent an early albumin permeability defect in isolated glomeruli from streptozotocin-treated rats 11
Aminoguanidine ameliorates diabetes-associated atherosclerosis in apolipoprotein-E KO mice 11
An early albumin permeability defect is prevented by strict glycemic control in incipient diabetic nephropathy 10
Gestational diabetes mellitus: Impact of adherence on patient management and maternal-neonatal complications 9
Analysis of left atrial performance in patients with type 2 diabetes mellitus without overt cardiac disease and inducible ischemia: high prevalence of increased systolic force related to enhanced left ventricular systolic longitudinal function 9
Disfunzione endoteliale: obiettivo terapeutico primario nel diabete 9
Disfunzione diastolica e diabete 9
Acarbose vs metformin for new-onset type 2 diabetes 8
Impiego di associazioni precostituite di ACE-inibitori e sartani in diabetologia: presente e futuro 8
Alterazioni del tessuto adiposo, del metabolismo lipidico e delle adipochine nella sindrome metabolica (SM) 8
L'enzima di conversione dell'angiotensina 2 regola il metabolismo glucidico 7
Appropriatezza prescrittiva di ACE-Inibitori e sartani 7
Oltre l'anno 2000: una rivoluzione per ACE-inibitori e sartani. Dai grandi trial alle nuove strategie terapeutiche 5
Vasoactive peptides and the kidney 4
Dalla Best Clinical Practice all'appropriatezza e sostenibilità dell'impiego di ACE-I e Sartani in Diabetologia 4
Ruolo della resistenza insulinica nelle malattie vascolari 4
Systemic osteoprotegerin delivery shows pro-atherosclerotic activity in diabetic apolipoprotein E-null mice 3
Real-World Retrospective Study into the Effects of Oral Semaglutide (As a Switchover or Add-On Therapy) in Type 2 Diabetes 3
Il danno renale alla luce delle nuove Linee Guida ESH/ESC 2007 3
Il trial clinico: dai grandi numeri al singolo individuo 3
Vasoactive peptides and the kidney 3
Lo stress ossidativo nella pratica clinica: come, dove e quando 3
Totale 6.704
Categoria #
all - tutte 18.137
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.137


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019416 0 0 0 0 0 0 0 0 0 0 266 150
2019/20201.482 96 76 61 229 98 176 139 174 160 157 75 41
2020/2021744 62 59 49 100 62 76 46 58 34 102 28 68
2021/2022544 20 28 17 48 17 53 29 12 57 60 47 156
2022/2023981 70 113 85 131 98 183 3 92 137 14 41 14
2023/2024951 41 232 67 55 99 77 190 138 22 27 3 0
Totale 6.718